The Science and Supply of GLP-1s
The a16z Show19 Kesä 2024

The Science and Supply of GLP-1s

Brooke Boyarsky Pratt, founder and CEO of knownwell, joins Vineeta Agarwala, general partner at a16z Bio + Health.

Together, they talk about the value of obesity medicine practitioners, patient-centric medical homes, and how Brooke believes the metabolic health space will evolve over time.

This is the second episode in Raising Health’s series on the science and supply of GLP-1s. Listen to last week's episode to hear from Carolyn Jasik, Chief Medical Officer at Omada Health, on GLP-1s from a clinical perspective.

Listen to more from Raising Health’s series on GLP-1s:

The science of satiety: https://raisinghealth.simplecast.com/episodes/the-science-and-supply-of-glp-1s-with-carolyn-jasik

Payers, providers and pricing: https://raisinghealth.simplecast.com/episodes/the-science-and-supply-of-glp-1s-with-chronis-manolis

Stay Updated:

Let us know what you think: https://ratethispodcast.com/a16z

Find a16z on Twitter: https://twitter.com/a16z

Find a16z on LinkedIn: https://www.linkedin.com/company/a16z

Subscribe on your favorite podcast app: https://a16z.simplecast.com/

Follow our host: https://twitter.com/stephsmithio

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaksot(1000)

Measuring & Managing Community Orgs, Developer Relations and Beyond

Measuring & Managing Community Orgs, Developer Relations and Beyond

Okay, so we know community is important -- whether for developer relations for your product or other types of communities -- but how do we measure the success of community initiatives and even artifac...

30 Elo 202033min

Reining in Complexity: Data Science & Future of AI/ML Businesses

Reining in Complexity: Data Science & Future of AI/ML Businesses

There is no spoon. Or rather, “There is no such thing as ‘data’, there’s just frozen models”, argues Peter Wang, the co-founder and CEO of Anaconda — who also created the PyData conferences and grew t...

21 Elo 202044min

Online Learning and the Ed Tech Debate

Online Learning and the Ed Tech Debate

This episode is all about education and technology, a topic that’s especially top of mind this week as students in much of the country return to school—virtually. The intersection of learning and tech...

17 Elo 202048min

On Vaccines and Vaccinology, in COVID and Beyond

On Vaccines and Vaccinology, in COVID and Beyond

WHEN are we going to have a COVID-19 vaccine, and how the heck are we going from (what’s been traditionally been up to) 12 years or so of vaccine development compressed into 12 months or so? What will...

14 Elo 202056min

Turning Open Source Developers Into Superfans

Turning Open Source Developers Into Superfans

In this episode, we continue our community series with a recent discussion that applies to many kinds of community building. Today’s topic: How do you create a platform that people not only use, but t...

10 Elo 202045min

Journal Club: Slaying the Sleeper Cells of Aging with CAR T

Journal Club: Slaying the Sleeper Cells of Aging with CAR T

CAR T therapy is a groundbreaking medicine that uses engineered T cells to attack cancer. But CAR T cells (that is, chimeric antigen receptor T cells) can be programmed to recognize a huge range of ta...

9 Elo 202018min

Working, Making, Creating in Public... and Private

Working, Making, Creating in Public... and Private

We're living in an unprecedented era of online collaboration, coordination, and creation. All kinds of people are coming together -- whether in an open source project or company, an R&D initiative, a ...

2 Elo 202047min

GPT-3: What's Hype, What's Real on the Latest in AI

GPT-3: What's Hype, What's Real on the Latest in AI

In this episode -- cross posted from our 16 Minutes show feed -- we cover all the buzz around GPT-3, the pre-trained machine learning model from OpenAI that’s optimized to do a variety of natural-lang...

30 Heinä 202033min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
rss-rahamania
taloudellinen-mielenrauha
ostan-asuntoja-podcast
herrasmieshakkerit
rahapuhetta
juristipodi
rss-draivi
rss-sami-miettinen-neuvottelija
asuntoasiaa-paivakirjat
rss-lahtijat
rss-seuraava-potilas
rss-paasipodi
pomojen-suusta
rss-h-asselmoilanen
rss-rikasta-elamaa
rss-markkinointitrippi